A human mutant CD4 molecule resistant to HIV-1 binding restores helper T-lymphocyte functions in murine CD4-deficient mice

Experimental and Molecular Medicine

Volumn 39, Issue 1, 2007, Pages 1-7

  Kim, Dong Ku ^a   Satoko, Tahara Hanaoka ^b   Shinohara, Nobutsuna ^c   Nakauchi, Hiromitsu ^d  

^a CHA University   (South Korea)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Antigens, CD4; Aquired immunodefiency syndrome; CD4 positive T lymphocytes; HIV 1; Mice, transgenic; T lymphocytes, helper inducer

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 120;

ARTICLE; B LYMPHOCYTE ACTIVATION; BINDING AFFINITY; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; GENE MUTATION; HELPER CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; MOUSE; NONHUMAN; PROTEIN BINDING;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE; MUS; MUS MUSCULUS;

EID: 33847624617     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2007.1     Document Type: Article

References (25)

1. Biddison WE, Rao PE, Talle MM, Goldstein G, Shaw S. Possible involvement of the OKT4 molecule in T cell recognition of class II HLA antigen. J Exp Med 1982;156:1065-76
2. Clayton LK, Sieh M, Pious DA, Reinherz EL. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. Nature 1989;339:548-51
3. Coffin JM. HIV population dynamics in vivo: implication for genetic variation, pathogenesis, and therapy. Science 1995;267:483-9
4. Fleury S, Lamarre D, Meloche S, Ryu SE, Cantin C, Hendrickson WA, Sekaly RP. Mutational analysis of the interaction between CD4 and class II MHC: class II antigens contact CD4 on a surface opposite the gp120-binding site. Cell 1991;66:1037-49
5. Killeen N, Sawada S, Littman DR. Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4. EMBO 1993;12:1547-53
6. +. Proc Natl Acad Sci USA 1982;79:2365-9
7. Kunkel TA. Rapid and efficient site specific mutagenesis without phenotypic selection. Proc Natl Acad Sci USA 1985;82:488-92
8. Lamarre D, Ashikenazi A, Fleury S, Smith DH, Sekaly RP, Capon DJ. The MHC-binding and gp120-binding functions of CD4 are separable. Science 1989a;245:743-6
9. Lamarre D, Capon DJ, Karp DR, Gregory T, Long EO, Sekaly RP. Class II MHC molecules and the HIV gp120 envelop protein interact with functionally distinct regions of the CD4 molecule. EMBO J 1989b;8:3271-7
10. Landau NR, Warton M, Littman DR. The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4. Nature 1988;334:159-62
11. Law YM, Yeung RS, Mamalaki C, Kioussis D, Mark TW. Flavel RA. Human CD4 restores normal T cell development and function in mice deficient in murine CD4. J Exp Med 1994;179:1233-42
12. Maddon PJ, Littman DR, Godfrey M, Maddon DE, Chess L, Axel R. The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new membrane of the immunoglobulin gene family. Cell 1985;42:93-104
13. Manasky LM, Temin HM. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol 1995;69:5087-94
14. Mizukami T, Fuerst TR, Berger EA, Moss B. Binding region for human immunodeficiency virus (HIV) and epitopes for IHV-blocking monoclonal antibodies of the CD4 molecule define by site-directed mutagenesis. Proc Natl Acad Sci USA 1988;85:9273-7
15. Moebius U, Clayton LK, Abaraham S, Diener A, Yunis JJ, Harrison SC, Reinherz EL. Human immunodeficiency virus gp120 binding C′C″ ridge of CD4 domain I is also involved in interaction with class II histocompatibility complex molecules. Proc Natl Acad Sci USA 1992;89:12008-12
16. Moutouh, L, Corbeil J, Richman DD. Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure. Proc Natl Acad Sci USA 1996;93:6106-11
17. Peterson A, Seed B. Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell 1988;54:65-72
18. Poeschla E, Corbeau P, Wong-Staal F. Development of HIV vectors for anti-HIV gene therapy. Proc Natl Acad Sci USA 1996;93:11395-9
19. Robey E, Axel R. CD4: Collaboration in immune recognition and HIV infection. Cell 1990;60:697-700
20. Rosenstein Y, Burakoff S, Herrmann SH. HIV-gp120 can block CD4-class II MHC-mediated adhesion. J Immunol 1990;144:526-31
21. Ryu SE, Kwong PD, Truneh A, Poter TG, Arthos J, Rosenberg M, Dai XP, Xuong N, Axel R, Sweet RW, Hendrickson WA. Crystal sturucture of an HIV-binding recombinant fragment of human CD4. Nature 1990;348:419-26
22. Sanhadji K, Leissner P, Firouzi R, Pelloquin F, Kehrli L, Marigliano M, Calenda V, Ottmann M, Tardy JC, Mehtali M, Touraine JL. Experimental gene therapy: the transfer of Tat-inducible interferon genes protects human cells against HIV-1 challenge in vitro and in vivo in severe combined immunodeficient mice. AIDS 1997;11:977-86
23. Siddiqi MA, Tachibana M, Ohta S, Ikegami Y, Tahara-Hanaoka S, Huang Y, Shinohara N. Comparative analysis of the gp120-binding area of murine and human CD4 molecules. J Acqir Immune Defic Syndr Hum Rettrovirol 1997;14:7-12
24. Thomas PZ. James AT. Homologous recombination in human embryonic stem cells. Nat Biothechnol 2003;21:319-21
25. Williams AF, Barclay AN. The immunoglobulin superfamily-domains for cell surface recognition. Annu Rev Immunol 1988;6:381-405